Literature DB >> 26855948

A multifunctional bispecific antibody against Pseudomonas aeruginosa as a potential therapeutic strategy.

Iram J Haq1, Aaron Gardner1, Malcolm Brodlie1.   

Abstract

Entities:  

Year:  2016        PMID： 26855948      PMCID： PMC4716945          DOI： 10.3978/j.issn.2305-5839.2015.10.10

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  23 in total

Review 1.  The multiple signaling systems regulating virulence in Pseudomonas aeruginosa.

Authors:  Pol Nadal Jimenez; Gudrun Koch; Jessica A Thompson; Karina B Xavier; Robbert H Cool; Wim J Quax
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

Review 2.  Anti-bacterial monoclonal antibodies: back to the future?

Authors:  Martin B Oleksiewicz; Gábor Nagy; Eszter Nagy
Journal:  Arch Biochem Biophys       Date:  2012-06-13       Impact factor: 4.013

3.  Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis.

Authors:  R L Henry; C M Mellis; L Petrovic
Journal:  Pediatr Pulmonol       Date:  1992-03

4.  Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection.

Authors:  Carlos E Milla; James F Chmiel; Frank J Accurso; Donald R VanDevanter; Michael W Konstan; Geoffrey Yarranton; David E Geller
Journal:  Pediatr Pulmonol       Date:  2013-09-09

5.  Characterization of a humanized monoclonal antibody recognizing clumping factor A expressed by Staphylococcus aureus.

Authors:  Paul J Domanski; Pratiksha R Patel; Arnold S Bayer; Li Zhang; Andrea E Hall; Peter J Syribeys; Elena L Gorovits; Dawn Bryant; John H Vernachio; Jeff T Hutchins; Joseph M Patti
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 6.  Antibiotic allergy in cystic fibrosis.

Authors:  J S Parmar; S Nasser
Journal:  Thorax       Date:  2005-06       Impact factor: 9.139

Review 7.  Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective.

Authors:  Anders Folkesson; Lars Jelsbak; Lei Yang; Helle Krogh Johansen; Oana Ciofu; Niels Høiby; Søren Molin
Journal:  Nat Rev Microbiol       Date:  2012-11-13       Impact factor: 60.633

Review 8.  Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.

Authors:  Simon C Langton Hewer; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2014-11-10

Review 9.  Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review.

Authors:  Ana Margarida Sousa; Maria Olívia Pereira
Journal:  Pathogens       Date:  2014-08-18

10.  Targeted Antibiotic Prophylaxis for Lung Transplantation in Cystic Fibrosis Patients Colonised with Pseudomonas aeruginosa Using Multiple Combination Bactericidal Testing.

Authors:  Helmy Haja Mydin; Paul A Corris; Audrey Nicholson; John D Perry; Gerard Meachery; Emma C L Marrs; Steven Peart; Christine Fagan; James L Lordan; Andrew J Fisher; Frances K Gould
Journal:  J Transplant       Date:  2012-07-16
View more
  2 in total

Review 1.  The role of genetics and antibodies in sepsis.

Authors:  Evangelos J Giamarellos-Bourboulis; Steven M Opal
Journal:  Ann Transl Med       Date:  2016-09

2.  Secondary Metabolites Produced during Aspergillus fumigatus and Pseudomonas aeruginosa Biofilm Formation.

Authors:  Rafael Wesley Bastos; Daniel Akiyama; Thaila Fernanda Dos Reis; Ana Cristina Colabardini; Rafael Sanchez Luperini; Patrícia Alves de Castro; Regina Lúcia Baldini; Taícia Fill; Gustavo H Goldman
Journal:  mBio       Date:  2022-07-20       Impact factor: 7.786
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.